Filiz İzci1, Gözdem Özdem2, Ahmet Serkan İlgün3, Filiz Ağaçayak2, Tomris Duymaz4, Zeynep Erdoğan2, Gül Alço5, Filiz Elbüken5, Alper Öztürk6, Çetin Ordu5, Kübra Ceren Ateşal1, Özge İpek Doğan1, Fatma Aktepe5, Vahit Özmen7. 1. Department of Psychiatry, İstanbul Erenköy Training and Research Hospital, İstanbul, Turkey. 2. İstanbul Florence Nightangale Hospital, Breast Health Center, İstanbul, Turkey. 3. Department of General Surgery, İstanbul Taksim Training and Research Hospital, İstanbul, Turkey. 4. Department of Physiotherapy and Rehabilitation, İstanbul Bilgi University Faculty of Health Sciences, İstanbul, Turkey. 5. Gayrettepe Florence Nightingale Hospital, Breast Health Center, İstanbul, Turkey. 6. Department of General Surgery, Biruni University School of Medicine, İstanbul, Turkey. 7. Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey.
Abstract
OBJECTIVE: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders and psychiatric disorders such as anxiety and depression. The main objective of our research is to study of the pre-treatment and post-treatment anxiety, depression, sleep and sexual function levels in the patients with breast cancer. MATERIALS AND METHODS: Fifty-six patients with breast cancer and 52 healthy women have participated in our study. In order to determine the anxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases for patients with breast cancer and our control group. RESULTS: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexual and sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p<0.05). According to the scale scores calculated before and after treatment, there was a significant decrease in HADS and PSQI scores, whereas SEX scores have been increased significantly (p<0.05). CONCLUSION: According to the findings of our study, anxiety, depression, sexual dysfunction and sleep disorders in patients with breast cancer are far more explicit in the pre-treatment phase than post-treatment phase. Therefore, it is crucial to psycho-socially support patients with breast cancer in the early periods before starting the treatment after diagnosis.
OBJECTIVE: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders and psychiatric disorders such as anxiety and depression. The main objective of our research is to study of the pre-treatment and post-treatment anxiety, depression, sleep and sexual function levels in the patients with breast cancer. MATERIALS AND METHODS: Fifty-six patients with breast cancer and 52 healthy women have participated in our study. In order to determine the anxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases for patients with breast cancer and our control group. RESULTS: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexual and sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p<0.05). According to the scale scores calculated before and after treatment, there was a significant decrease in HADS and PSQI scores, whereas SEX scores have been increased significantly (p<0.05). CONCLUSION: According to the findings of our study, anxiety, depression, sexual dysfunction and sleep disorders in patients with breast cancer are far more explicit in the pre-treatment phase than post-treatment phase. Therefore, it is crucial to psycho-socially support patients with breast cancer in the early periods before starting the treatment after diagnosis.
Authors: Margaret Chamberlain Wilmoth; Elizabeth Ann Coleman; Steven C Smith; Carla Davis Journal: Oncol Nurs Forum Date: 2004-11-16 Impact factor: 2.172
Authors: Amy E Lowery-Allison; Steven D Passik; Matthew R Cribbet; Ruth A Reinsel; Barbara O'Sullivan; Larry Norton; Kenneth L Kirsh; Neil B Kavey Journal: Palliat Support Care Date: 2017-05-16
Authors: Teletia R Taylor; Edward D Huntley; Kepher Makambi; Jennifer Sween; Lucile L Adams-Campbell; Wayne Frederick; Thomas A Mellman Journal: Psychooncology Date: 2011-06-05 Impact factor: 3.955
Authors: Thais Sousa Rodrigues Guedes; Marcello Barbosa Otoni Gonçalves Guedes; Rebeca de Castro Santana; José Felipe Costa da Silva; Amanda Almeida Gomes Dantas; Mirari Ochandorena-Acha; Marc Terradas-Monllor; Javier Jerez-Roig; Dyego Leandro Bezerra de Souza Journal: Int J Environ Res Public Health Date: 2022-09-21 Impact factor: 4.614